Abstract 5732: Identification and functional analysis of chloride intracellular channel protein 1-binding peptide and its uses for ProTac-based cancer therapy

Abstract Targeted therapy using antibodies that treat only certain cancer cells is currently being studied because it causes less side effects on normal cells. Compared to antibodies, peptides are relatively smaller and have higher tissue penetration ability and lower immunogenicity. Chloride intracellular channel protein1 (CLIC1) is a metamorphic protein as it can exist in two forms: soluble globular protein in the cytoplasm or transmembrane protein. CLIC1 is related to cancer angiogenesis, cell migration and metastasis and is upregulated in various types of cancer, including hepatocellular carcinoma and lung cancer, presenting it as a promising therapeutic cancer target. In this study, we identified a peptide candidate (CLIC1pep) that binds to CLIC1 using phage display. The affinity and specific binding of CLIC1pep to CLIC1 was validated by SPR, ELISA, and pull-down assays. CLIC1pep linked to a cell-penetrating peptide (R7) (R7-CLIC1pep) showed an increased cell penetration and binding to CLIC1 in the cytoplasm, whereas it did not induce tumor cell death. However, R7-linked CLIC1pep inhibited the membrane insertion of CLIC1 and reduced the migration and invasion of cancer cells through reducing the p-ERK levels. Moreover, R7-CLIC1pep-linked E3 ligase peptide was synthesized for a ProTAC against CLIC1 and degraded CLIC1 in tumor cells. These results suggest that R7-CLIC1pep and R7-CLIC1pep-linked E3 ligase peptide hold a potential for a ProTac-based cancer therapy of CLIC1-high tumors. Citation Format: Aryeong Lee, Byungheon Lee. Identification and functional analysis of chloride intracellular channel protein 1-binding peptide and its uses for ProTac-based cancer therapy [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 5732.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-03
DOI
https://doi.org/10.1158/1538-7445.am2026-5732
Primary Topic
Ion channel regulation and function
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 5732: Identification and functional analysis of chloride intracellular channel protein 1-binding peptide and its uses for ProTac-based cancer therapy

Aryeong Lee, Byungheon Lee
Cancer Research
Ion channel regulation and function
article

Abstract 5732: Identification and functional analysis of chloride intracellular channel protein 1-binding peptide and its uses for ProTac-based cancer therapy

Aryeong Lee, Byungheon Lee
article en

Abstract

Abstract Targeted therapy using antibodies that treat only certain cancer cells is currently being studied because it causes less side effects on normal cells. Compared to antibodies, peptides are relatively smaller and have higher tissue penetration ability and lower immunogenicity. Chloride intracellular channel protein1 (CLIC1) is a metamorphic protein as it can exist in two forms: soluble globular protein in the cytoplasm or transmembrane protein. CLIC1 is related to cancer angiogenesis, cell migration and metastasis and is upregulated in various types of cancer, including hepatocellular carcinoma and lung cancer, presenting it as a promising therapeutic cancer target. In this study, we identified a peptide candidate (CLIC1pep) that binds to CLIC1 using phage display. The affinity and specific binding of CLIC1pep to CLIC1 was validated by SPR, ELISA, and pull-down assays. CLIC1pep linked to a cell-penetrating peptide (R7) (R7-CLIC1pep) showed an increased cell penetration and binding to CLIC1 in the cytoplasm, whereas it did not induce tumor cell death. However, R7-linked CLIC1pep inhibited the membrane insertion of CLIC1 and reduced the migration and invasion of cancer cells through reducing the p-ERK levels. Moreover, R7-CLIC1pep-linked E3 ligase peptide was synthesized for a ProTAC against CLIC1 and degraded CLIC1 in tumor cells. These results suggest that R7-CLIC1pep and R7-CLIC1pep-linked E3 ligase peptide hold a potential for a ProTac-based cancer therapy of CLIC1-high tumors. Citation Format: Aryeong Lee, Byungheon Lee. Identification and functional analysis of chloride intracellular channel protein 1-binding peptide and its uses for ProTac-based cancer therapy [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 5732.

Cancer ResearchVol. 86(7_Supplement)
Kyungpook National University (KR)
Good health and well-being
Openalex Percentile: Top 7%
Ion channel regulation and function
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.